Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385753670> ?p ?o ?g. }
Showing items 1 to 97 of
97
with 100 items per page.
- W4385753670 endingPage "110872" @default.
- W4385753670 startingPage "110872" @default.
- W4385753670 abstract "Compare the efficacy and safety of sitagliptin, dapagliflozin, and lobeglitazone in patients with uncontrolled type 2 diabetes, despite metformin and sulfonylurea therapy.The study randomized patients into three groups, receiving sitagliptin 100 mg, dapagliflozin 10 mg, or lobeglitazone 0.5 mg daily (n = 26 each) and monitored changes in biochemical parameters and body composition for 24 months. The primary efficacy endpoint was changes in HbA1c at 24 months.The mean change in HbA1c in the sitagliptin, dapagliflozin, and lobeglitazone groups was -0.81 ± 0.21%, -1.05 ± 0.70%, and -1.08 ± 0.98%, after 24 months. Dapagliflozin treatment significantly lowered systolic blood pressure by 5.5 mmHg and alanine aminotransferase levels. Dapagliflozin and lobeglitazone treatment significantly reduced proteinuria and insulin resistance. Dapagliflozin decreased whole body fat percentage by 1.2%, whereas sitagliptin and lobeglitazone increased it by 1.1% and 1.8%, respectively. Whole body muscle percentage increased in the dapagliflozin group and decreased in the lobeglitazone group. The safety profiles of the three treatments were comparable.All three drugs displayed good glucose-lowering efficacy and comparable safety profiles. However, dapagliflozin therapy produced favorable changes in body composition. Dapagliflozin may be a suitable adjunct therapy for patients with type 2 diabetes seeking to improve their body composition." @default.
- W4385753670 created "2023-08-12" @default.
- W4385753670 creator A5006157968 @default.
- W4385753670 creator A5009982632 @default.
- W4385753670 creator A5016802409 @default.
- W4385753670 creator A5046364417 @default.
- W4385753670 date "2023-09-01" @default.
- W4385753670 modified "2023-10-11" @default.
- W4385753670 title "Comparison of therapeutic efficacy and safety of sitagliptin, dapagliflozin, or lobeglitazone adjunct therapy in patients with type 2 diabetes mellitus inadequately controlled on sulfonylurea and metformin: Third agent study" @default.
- W4385753670 cites W2008577165 @default.
- W4385753670 cites W2028064800 @default.
- W4385753670 cites W2062560800 @default.
- W4385753670 cites W2082432305 @default.
- W4385753670 cites W2085618141 @default.
- W4385753670 cites W2106043930 @default.
- W4385753670 cites W2118133237 @default.
- W4385753670 cites W2144829836 @default.
- W4385753670 cites W2151345870 @default.
- W4385753670 cites W2160234571 @default.
- W4385753670 cites W2171512247 @default.
- W4385753670 cites W2173923871 @default.
- W4385753670 cites W2180946184 @default.
- W4385753670 cites W2181940024 @default.
- W4385753670 cites W2515456868 @default.
- W4385753670 cites W2765973564 @default.
- W4385753670 cites W2790284368 @default.
- W4385753670 cites W2891409258 @default.
- W4385753670 cites W2895576044 @default.
- W4385753670 cites W2937439076 @default.
- W4385753670 cites W2945554427 @default.
- W4385753670 cites W2951066395 @default.
- W4385753670 cites W2966070710 @default.
- W4385753670 cites W3004109662 @default.
- W4385753670 cites W3025483226 @default.
- W4385753670 cites W3086213814 @default.
- W4385753670 cites W3112375060 @default.
- W4385753670 cites W4206946749 @default.
- W4385753670 cites W4212810717 @default.
- W4385753670 cites W4241952593 @default.
- W4385753670 cites W4256525495 @default.
- W4385753670 cites W4308040595 @default.
- W4385753670 doi "https://doi.org/10.1016/j.diabres.2023.110872" @default.
- W4385753670 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37574137" @default.
- W4385753670 hasPublicationYear "2023" @default.
- W4385753670 type Work @default.
- W4385753670 citedByCount "0" @default.
- W4385753670 crossrefType "journal-article" @default.
- W4385753670 hasAuthorship W4385753670A5006157968 @default.
- W4385753670 hasAuthorship W4385753670A5009982632 @default.
- W4385753670 hasAuthorship W4385753670A5016802409 @default.
- W4385753670 hasAuthorship W4385753670A5046364417 @default.
- W4385753670 hasConcept C126322002 @default.
- W4385753670 hasConcept C126894567 @default.
- W4385753670 hasConcept C134018914 @default.
- W4385753670 hasConcept C2777180221 @default.
- W4385753670 hasConcept C2777422806 @default.
- W4385753670 hasConcept C2778854520 @default.
- W4385753670 hasConcept C2779284873 @default.
- W4385753670 hasConcept C2779306644 @default.
- W4385753670 hasConcept C2780323712 @default.
- W4385753670 hasConcept C555293320 @default.
- W4385753670 hasConcept C71924100 @default.
- W4385753670 hasConcept C90924648 @default.
- W4385753670 hasConceptScore W4385753670C126322002 @default.
- W4385753670 hasConceptScore W4385753670C126894567 @default.
- W4385753670 hasConceptScore W4385753670C134018914 @default.
- W4385753670 hasConceptScore W4385753670C2777180221 @default.
- W4385753670 hasConceptScore W4385753670C2777422806 @default.
- W4385753670 hasConceptScore W4385753670C2778854520 @default.
- W4385753670 hasConceptScore W4385753670C2779284873 @default.
- W4385753670 hasConceptScore W4385753670C2779306644 @default.
- W4385753670 hasConceptScore W4385753670C2780323712 @default.
- W4385753670 hasConceptScore W4385753670C555293320 @default.
- W4385753670 hasConceptScore W4385753670C71924100 @default.
- W4385753670 hasConceptScore W4385753670C90924648 @default.
- W4385753670 hasFunder F4320309998 @default.
- W4385753670 hasFunder F4320316485 @default.
- W4385753670 hasLocation W43857536701 @default.
- W4385753670 hasLocation W43857536702 @default.
- W4385753670 hasOpenAccess W4385753670 @default.
- W4385753670 hasPrimaryLocation W43857536701 @default.
- W4385753670 hasRelatedWork W1981216675 @default.
- W4385753670 hasRelatedWork W2141848583 @default.
- W4385753670 hasRelatedWork W2431567440 @default.
- W4385753670 hasRelatedWork W3080430714 @default.
- W4385753670 hasRelatedWork W3158606533 @default.
- W4385753670 hasRelatedWork W4200447447 @default.
- W4385753670 hasRelatedWork W4210880101 @default.
- W4385753670 hasRelatedWork W4252524655 @default.
- W4385753670 hasRelatedWork W4310968766 @default.
- W4385753670 hasRelatedWork W4362456215 @default.
- W4385753670 hasVolume "203" @default.
- W4385753670 isParatext "false" @default.
- W4385753670 isRetracted "false" @default.
- W4385753670 workType "article" @default.